CN Patent

CN102149377A — 决奈达隆在制备用于预防中风或短暂性缺血发作的药物中的用途

Assigned to Sanofi Aventis France · Expires 2011-08-10 · 15y expired

What this patent protects

决奈达隆在制备用于预防中风或短暂性缺血发作的药物中的用途。

USPTO Abstract

决奈达隆在制备用于预防中风或短暂性缺血发作的药物中的用途。

Drugs covered by this patent

landiolol-hydrochloride (LANDIOLOL HYDROCHLORIDE)

Patent Metadata

Patent number: CN102149377A
Jurisdiction: CN
Classification: —
Expires: 2011-08-10
Drug substance claim: No
Drug product claim: No
Assignee: Sanofi Aventis France
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.